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ARI

:   acute respiratory infection

ED

:   emergency department

ED

:   emergency department

*Hi*

:   *Haemophilus influenzae*

hRV

:   human rhinovirus

IQR

:   interquartile range

*Mc*

:   *Moraxella catarrhalis*

NPA

:   nasopharyngeal aspirate

PIV

:   parainfluenza viruses

PyV

:   polyomaviruses

qPCR

:   quantitative PCR

RCH

:   Royal Children\'s Hospital

RSV

:   respiratory syncytial virus

*Sp*

:   *Streptococcus pneumoniae*

INTRODUCTION {#resp13179-sec-0006}
============

Acute respiratory infection (ARI) is a significant cause of childhood illness worldwide.[1](#resp13179-bib-0001){ref-type="ref"} Respiratory viruses, such as respiratory syncytial virus (RSV) and human rhinovirus (hRV) are the most common cause. While disease is often mild with cold‐like symptoms, it can progress to severe presentations such as bronchiolitis or pneumonia requiring hospitalization or resulting in death. RSV accounts for over three million paediatric hospitalizations per year.[2](#resp13179-bib-0002){ref-type="ref"} Outgrowth of bacteria known to asymptomatically colonize the upper airway of young children, including *Streptococcus pneumoniae*, *Haemophilus influenzae* and *Moraxella catarrhalis*, has been reported during viral ARI, often in association with increased disease severity.[3](#resp13179-bib-0003){ref-type="ref"}, [4](#resp13179-bib-0004){ref-type="ref"}, [5](#resp13179-bib-0005){ref-type="ref"}, [6](#resp13179-bib-0006){ref-type="ref"}, [7](#resp13179-bib-0007){ref-type="ref"}, [8](#resp13179-bib-0008){ref-type="ref"}, [9](#resp13179-bib-0009){ref-type="ref"}, [10](#resp13179-bib-0010){ref-type="ref"}, [11](#resp13179-bib-0011){ref-type="ref"}, [12](#resp13179-bib-0012){ref-type="ref"}, [13](#resp13179-bib-0013){ref-type="ref"}, [14](#resp13179-bib-0014){ref-type="ref"} The contribution of viral/bacterial co‐infections to disease severity has been well‐documented in co‐infections caused by influenza viruses and *S. pneumoniae* in adults,[15](#resp13179-bib-0015){ref-type="ref"} however, the role of bacteria during paediatric viral ARI is less clear.[16](#resp13179-bib-0016){ref-type="ref"} Synergistic interactions between respiratory viruses and bacteria have been demonstrated in mechanistic studies, including increased attachment to airway epithelium and enhancement of immune evasion strategies.[17](#resp13179-bib-0017){ref-type="ref"}, [18](#resp13179-bib-0018){ref-type="ref"}, [19](#resp13179-bib-0019){ref-type="ref"}, [20](#resp13179-bib-0020){ref-type="ref"}, [21](#resp13179-bib-0021){ref-type="ref"}, [22](#resp13179-bib-0022){ref-type="ref"}, [23](#resp13179-bib-0023){ref-type="ref"} Consideration of potentially pathogenic bacteria may be important in the diagnosis, treatment and prevention of paediatric ARI.

The majority of paediatric ARI studies investigating associations between specific viral/bacterial interactions and disease severity have taken place in temperate climates in the northern hemisphere.[6](#resp13179-bib-0006){ref-type="ref"}, [7](#resp13179-bib-0007){ref-type="ref"}, [8](#resp13179-bib-0008){ref-type="ref"}, [9](#resp13179-bib-0009){ref-type="ref"}, [10](#resp13179-bib-0010){ref-type="ref"}, [11](#resp13179-bib-0011){ref-type="ref"} These climates are characterized by distinct seasonal epidemics of respiratory viruses peaking in winter each year.[24](#resp13179-bib-0024){ref-type="ref"} The present study setting of Brisbane, Australia, has a subtropical climate with only moderate temperature variations, where the RSV seasonal epidemic usually peaks in early autumn (March--April), depending on rainfall during the preceding summer.[4](#resp13179-bib-0004){ref-type="ref"}, [24](#resp13179-bib-0024){ref-type="ref"} Differences in the environment of study locations may affect the carriage of respiratory viruses and bacteria, thereby influencing the potential for clinically significant interactions to occur between pathogens. We and others have previously reported increased co‐detection of *H. influenzae* and *S. pneumoniae* with RSV in Brisbane‐based cohorts of children with ARI[3](#resp13179-bib-0003){ref-type="ref"}, [4](#resp13179-bib-0004){ref-type="ref"}; however, the resulting effect on disease severity has not been investigated. In the present study, we further characterized the respiratory viruses and colonizing bacteria present during viral ARI, and their associations with disease severity, in a cohort of young children presenting at the emergency department (ED) of the Royal Children\'s Hospital (RCH), Brisbane.

METHODS {#resp13179-sec-0007}
=======

Study population and sample collection {#resp13179-sec-0008}
--------------------------------------

Children aged less than 2 years and presenting with symptoms of bronchiolitis, wheeze or asthma to RCH were recruited throughout 2011--2014. Participants with serious co‐morbidities, gestational age \< 37 weeks, birth weight \< 2.5 kg or requiring significant resuscitation were excluded. Admission to hospital, use of supplemental oxygen, use of assisted ventilation and previous medical history was recorded. Severity of illness was assessed using a modified Wood\'s Clinical Asthma Score (Table [S1](#resp13179-supitem-0001){ref-type="supplementary-material"} in Appendix [S1](#resp13179-supitem-0001){ref-type="supplementary-material"}, Supplementary Information), validated for use in children up to 2 years of age.[25](#resp13179-bib-0025){ref-type="ref"} This scoring system resulted in a disease severity score between 0 (well) and 10 (severe disease). Nasopharyngeal aspirates (NPAs) were taken by trained personnel following routine procedures, centrifuged and the supernatant stored at −80 °C.

Six to eight weeks later, participants were requested to return for a convalescent visit. A questionnaire collecting additional demographic and medical history data was completed. Current symptoms (if any) were recorded and children with evidence of sinus or ear infections were excluded. Nasal swabs (2011--2012) or nasal washes (2013--2014) were collected by trained personnel following routine procedures and stored at −80 °C.

The present study was approved by the human research ethics committee of Children\'s Health Queensland Health and Hospital Service (approval number HREC/11/QRCH/47). Parents gave written consent for their children to participate in the study.

Pathogen detection {#resp13179-sec-0009}
------------------

Nucleic acid extraction and screening for 17 viruses was conducted using previously described quantitative (q) PCR assays (Table [S2](#resp13179-supitem-0001){ref-type="supplementary-material"} in Appendix [S1](#resp13179-supitem-0001){ref-type="supplementary-material"}, Supplementary Information).[26](#resp13179-bib-0026){ref-type="ref"} Virus detection included RSV‐A, RSV‐B, parainfluenza virus 1--3, influenza A and B viruses, hRV, metapneumovirus, human adenovirus, human bocavirus, human enterovirus, polyomaviruses WU and KI and coronaviruses HKU1, OC43, NL63 and 29E.

Bacterial loads were determined for each sample using qPCR assays for *S. pneumoniae,* [27](#resp13179-bib-0027){ref-type="ref"} *M. catarrhalis* [28](#resp13179-bib-0028){ref-type="ref"} and *H. influenzae* [29](#resp13179-bib-0029){ref-type="ref"} (Table [S2](#resp13179-supitem-0001){ref-type="supplementary-material"} in Appendix [S1](#resp13179-supitem-0001){ref-type="supplementary-material"}, Supplementary Information). Since cross‐reactivity of the *S. pneumoniae* assay, targeting the pneumolysin gene *ply*, has been reported between closely related *Streptococcus* species, the presence of *S. pneumoniae* was confirmed through a real‐time PCR assay for autolysin (*lytA*).[30](#resp13179-bib-0030){ref-type="ref"} The total microbial load of each sample was also estimated using a qPCR assay targeting the 16S ribosomal RNA gene.

Statistical analysis {#resp13179-sec-0010}
--------------------

Statistical analysis was carried out in R 3.0.1.[31](#resp13179-bib-0031){ref-type="ref"} Univariable analysis was carried out using the epicalc package.[32](#resp13179-bib-0032){ref-type="ref"} Variables that were significant at *P* \< 0.05 in the univariable analysis were used in logistic regression to model factors contributing to the detection of RSV, hRV, multiple viral species in a sample, *S. pneumoniae*, *H. influenzae* and *M. catarrhalis*, with adjustment for confounding factors (age, sex, history of wheezing illness and season of ED visit). Firth\'s penalised likelihoods were used to correct for small sample bias with the logistf package.[33](#resp13179-bib-0033){ref-type="ref"} Variables that had *P* values \< 0.1 in the logistic regression models were entered into a single partial correlation matrix using the ppor package.[34](#resp13179-bib-0034){ref-type="ref"} Partial correlations with *P* values \< 0.05 were viewed in Cytoscape 3.3.0[35](#resp13179-bib-0035){ref-type="ref"} as an interaction network. Such analysis techniques have been used effectively by others[36](#resp13179-bib-0036){ref-type="ref"} to investigate interactions between viruses and bacteria in the respiratory tract. This analysis was also repeated using siblings, childcare attendance, history of severe ARI (i.e. those requiring hospitalization) and antibiotic usage in the last year as additional confounding factors, for participants with available data.

To analyse the effect of pathogen detection and interactions on disease severity, a linear regression model for severity score, and logistic regression models for admission to hospital and use of supplemental oxygen, were used with adjustment for confounding factors. For each, a simple model was built that included the confounding factors and detection of RSV, hRV, multiple viruses, *S. pneumoniae*, *H. influenzae* and *M. catarrhalis*, and multiple interaction models were built to reflect the co‐detections between specific pathogens identified in the partial correlation analysis.

In the convalescent samples, there was insufficient statistical power to investigate associations between pathogens; however, the difference between bacterial loads at the acute and convalescent visit was analysed using Wilcoxon matched‐pairs signed rank tests in Prism 7 (GraphPad Software, La Jolla, CA, USA).

RESULTS {#resp13179-sec-0011}
=======

Patient demographics and pathogen detection {#resp13179-sec-0012}
-------------------------------------------

NPAs were collected from 60 infants and young children with ARI symptoms between September 2011 and October 2014. Two samples were virus negative and were excluded from analysis. Demographic, clinical and pathogen detection data from the remaining 58 participants are reported in Table [1](#resp13179-tbl-0001){ref-type="table"}. Follow‐up questionnaires collecting additional demographic data were completed for 40 (69.0%) of the 58 participants and are also reported in Table [1](#resp13179-tbl-0001){ref-type="table"}. RSV and hRV were the most commonly detected viruses. Detection of multiple viral species in a patient was frequent, with up to four viruses detected in one sample. RSV was the most common sole virus observed (17 of 32 samples), while hRV was the most frequent co‐viral pathogen (20 of 26 samples). Bacterial DNA was detected in all 58 samples, and 48 (83%) of participants were colonized by at least one of the three targeted species. A total of 17 (29%) participants were colonized by all three target species.

###### 

Participant characteristics and pathogen detection

  ------------------------------------------------------------------------ ----------------------------------------------------------
  Number of samples                                                        58
  *Demographics*                                                           
  Median age in months (IQR)                                               4.8 (2.4,8.4)
  Male (%)                                                                 31 (53.4)
  ED visit during autumn/winter (%)                                        35 (60.3)
  Diagnosed asthma (%)                                                     2 (3.4)
  History of previous wheezing illness (%)                                 16 (22.2)
  Siblings (%)                                                             29 of 40 (72.5)[\*](#resp13179-note-0002){ref-type="fn"}
  Childcare attendance (%)                                                 12 of 40 (30.0)[\*](#resp13179-note-0002){ref-type="fn"}
  History of severe (hospitalized) ARI (%)                                 27 of 39 (69.2)[\*](#resp13179-note-0002){ref-type="fn"}
  Antibiotics prescribed in the last year (%)                              12 of 38 (31.6)[\*](#resp13179-note-0002){ref-type="fn"}
  *Clinical parameters*                                                    
  Received supplemental oxygen in ED (%)                                   11 (20.0)
  Admitted to hospital (%)                                                 31 (57.4)
  Received assisted ventilation in ED (%)                                  4 (7.3)
  Median clinical disease severity score (IQR)                             1 (0.5,2)
  *Severity score criteria*                                                
  Median score -- oxygen saturation (IQR)                                  0 (0,0)
  Median score -- inspiratory breath sounds (IQR)                          0 (0,0)
  Median score -- expiratory wheezing (IQR)                                0.5 (0,1)
  Median score -- accessory muscles (IQR)                                  0.5 (0,1)
  Median score -- cerebral function (IQR)                                  0 (0,0)
  *Bacterial detection*                                                    
  *S. pneumoniae* (%)                                                      26 (44.8)
  *H. influenzae* (%)                                                      28 (48.3)
  *M. catarrhalis* (%)                                                     42 (72.4)
  *S. pneumoniae ply* load[†](#resp13179-note-0003){ref-type="fn"} (IQR)   2.1 × 10^1^ (0, 3.5 × 10^3^)
  *H. influenzae* load[†](#resp13179-note-0003){ref-type="fn"} (IQR)       0 (0, 4.0 × 10^3^)
  *M. catarrhalis* load[†](#resp13179-note-0003){ref-type="fn"} (IQR)      5.6 × 10^2^ (0, 1.3 × 10^4^)
  Total microbial load[‡](#resp13179-note-0004){ref-type="fn"} (IQR)       1.5 × 10^5^ (3.9 × 10^4^, 6.3 × 10^5^)
  *Viral detection*                                                        
  RSV (%)                                                                  29 (50.0)
  RSV‐A (%)                                                                21 (36.2)
  RSV‐B (%)                                                                8 (13.8)
  hRV (%)                                                                  28 (48.3)
  Enteroviruses (%)                                                        8 (13.8)
  PIV (%)                                                                  7 (12.1)
  PIV‐1 (%)                                                                0 (0)
  PIV‐2 (%)                                                                2 (3.4)
  PIV‐3 (%)                                                                5 (8.6)
  Metapneumovirus (%)                                                      5 (8.6)
  Influenza A virus (%)                                                    2 (3.4)
  Influenza B virus (%)                                                    0 (0)
  Adenovirus (%)                                                           6 (10.3)
  Bocavirus (%)                                                            4 (6.9)
  Polyomaviruses (%)                                                       5 (8.6)
  Coronaviruses (%)                                                        2 (3.4)
  No. of viral species detected per sample (IQR)                           1 (1, 2)
  Single virus detected (%)                                                32 (55.2)
  Multiple viruses detected (%)                                            26 (44.8)
  ------------------------------------------------------------------------ ----------------------------------------------------------

These data were collected by questionnaire during the convalescent visit and were only available for a subset (38--40) of participants.

Median genomes per μL.

Median 16S ribosomal RNA gene copies per μL.

ARI, acute respiratory infection; ED, emergency department; hRV, human rhinovirus; IQR, interquartile range; PIV, parainfluenza viruses; RSV, respiratory syncytial virus.

Pathogen interactions {#resp13179-sec-0013}
---------------------

In the univariable analysis (Table [S3](#resp13179-supitem-0001){ref-type="supplementary-material"} in Appendix [S1](#resp13179-supitem-0001){ref-type="supplementary-material"}, Supplementary Information), detection of multiple viruses, *S. pneumoniae* and *H. influenzae* were all associated with an increase in age (*P* = 0.021, *P* \< 0.001 and *P* \< 0.001, respectively). Enteroviruses, adenoviruses and bocaviruses were exclusively detected with other viruses, and hRV was also associated with the presence of multiple viruses (*P* \< 0.001). A negative association was observed between RSV and hRV (*P* \< 0.001). *H. influenzae* colonization was positively associated with *M. catarrhalis* and *S. pneumoniae* (*P* = 0.013 and *P* = 0.009, respectively). *S. pneumoniae* colonization was also positively associated with detection of multiple viruses (*P* = 0.002), while *H. influenzae* colonization was associated with detection of polyomaviruses (*P* = 0.021). *S. pneumoniae* colonization was increased in the presence of RSV and hRV; however the differences were not statistically significant.

After adjustment for confounding factors, RSV and hRV remained negatively associated in the multivariable logistic regression models (*P* \< 0.001) (Fig. [1](#resp13179-fig-0001){ref-type="fig"}), while hRV and detection of multiple viruses remained positively associated (*P* = 0.007). A positive association between *S. pneumoniae* colonization and RSV detection was also observed (*P* = 0.030). Other associations identified in the univariable analysis were no longer significant at *P* \< 0.05.

![Associations between pathogen detections in multivariable logistic regression models with adjustment for confounding factors and detection of *Streptococcus pneumoniae* (A), *Haemophilus influenzae* (B), *Moraxella catarrhalis* (C), multiple viruses per sample (D), RSV (E) and hRV (F). Effect size (penalised maximum likelihoods) and 95% CI are shown. Black points represent likelihoods significant at *P* \< 0.05, dark grey points *P* \< 0.1 and light grey points *P* \> 0.1. ED, emergency department; *Hi*, *H. influenzae;* hRV, human rhinovirus; *Mc*, *M. catarrhalis;* PyV, polyomaviruses; RSV, respiratory syncytial virus; *Sp*, *S. pneumoniae*.](RESP-23-220-g001){#resp13179-fig-0001}

All variables that had associations with a significance level *P* \< 0.1 were included in the partial correlation matrix analysis and significant partial correlations (*P* \< 0.05) were visualized in an interaction network (Fig. [2](#resp13179-fig-0002){ref-type="fig"}). Increasing age was associated with *H. influenzae* and *S. pneumoniae* colonization, while decreasing age correlated with RSV and hRV detection. All associations observed in the logistic regression models persisted, and an association between *S. pneumoniae* colonization and hRV was observed.

![Interactions between viruses and bacteria in the upper respiratory tract during paediatric viral acute respiratory infection. Network built from output of partial correlation matrix analysis. Associations with *P* \< 0.01 (solid line) and *P* \< 0.05 (dashed line) are shown. Line thickness indicates magnitude of partial correlation. Positive (red lines) and negative (blue lines) correlations are shown. Age was the only confounding factor found to have a significant effect, indicated by arrow heads on edge lines. *Hi*, *Haemophilus influenzae*; hRV, human rhinovirus; *Mc*, *Moraxella catarrhalis*; RSV, respiratory syncytial virus; *Sp*, *Streptococcus pneumoniae*.](RESP-23-220-g002){#resp13179-fig-0002}

The above analyses were repeated with further adjustment for additional confounding factors using the subset of 40 samples for which this information was available, with similar results (Fig. [S1](#resp13179-supitem-0001){ref-type="supplementary-material"} in Appendix [S1](#resp13179-supitem-0001){ref-type="supplementary-material"}, Supplementary Information). Contact with other children, through siblings or childcare attendance, was found to influence *S. pneumoniae* and *H. influenzae* colonization.

Effect on disease severity {#resp13179-sec-0014}
--------------------------

Clinical disease severity scores for all 58 children ranged from 0 to 6 (median score 1) with 57% of participants admitted to hospital (Table [1](#resp13179-tbl-0001){ref-type="table"}). In the univariable analysis (Table [S3](#resp13179-supitem-0001){ref-type="supplementary-material"} in Appendix [S1](#resp13179-supitem-0001){ref-type="supplementary-material"}, Supplementary Information), increasing severity scores were associated with increasing age (*P* = 0.015) and a previous history of wheezing illness (*P* = 0.007). Detection of RSV (*P* = 0.031), multiple viruses (*P* = 0.035) and *S. pneumoniae* (*P* = 0.01) were also associated with increased severity scores.

In the multivariable models (Table [S4](#resp13179-supitem-0001){ref-type="supplementary-material"} in Appendix [S1](#resp13179-supitem-0001){ref-type="supplementary-material"}, Supplementary Information), higher severity scores were associated with RSV (*P* = 0.032), and specifically with RSV and *S. pneumoniae* co‐detection (*P* = 0.028). This association was particularly evident when the distribution of severity scores, separated by RSV and *S. pneumoniae* detection status, was visualized (Fig. [3](#resp13179-fig-0003){ref-type="fig"}). Severity scores were not associated with any other pathogen detection or patient demographic variable after adjustment for confounding factors. Admission to hospital and use of supplemental oxygen were also not associated with any variable (Table [S4](#resp13179-supitem-0001){ref-type="supplementary-material"} in Appendix [S1](#resp13179-supitem-0001){ref-type="supplementary-material"}, Supplementary Information).

![Clinical disease severity scores stratified by RSV and *Sp* co‐detection. Box and whisker plot with median and interquartile range is shown. + indicates positive detection of RSV or *Sp*, − indicates negative detection. RSV, respiratory syncytial virus; *Sp, Streptococcus pneumoniae.*](RESP-23-220-g003){#resp13179-fig-0003}

Pathogen detection at convalescence {#resp13179-sec-0015}
-----------------------------------

Nasal samples were available from only 27 infants and young children at convalescence, collected on average 8 weeks after the acute visit. Despite the small sample size, pathogen detection assays were performed and the results reported in Figure [S2](#resp13179-supitem-0001){ref-type="supplementary-material"} in Appendix [S1](#resp13179-supitem-0001){ref-type="supplementary-material"}, Supplementary Information. Eleven samples were virus positive and generally bacterial loads decreased between acute and convalescence visits.

DISCUSSION {#resp13179-sec-0016}
==========

There is growing recognition that interactions between viral and bacterial pathogens during ARI may affect disease severity and outcome. We have identified an association between RSV and *S. pneumoniae* in a Brisbane‐based paediatric cohort presenting to the ED with viral ARI. This interaction was associated with a significant enhancement of overall disease severity, as determined by criteria‐based scoring. While several other interactions between respiratory viruses and bacteria were observed, including hRV and *S. pneumoniae*, and hRV with other viruses, these were not strongly associated with clinical measures of disease.

While the present study determined *S. pneumoniae* nasopharyngeal colonization, and as such cannot comment on the occurrence of pneumococcal infection, the results provide further evidence that RSV and *S. pneumoniae* interact with a clinically relevant synergism. The RSV G glycoprotein has previously been shown to act as a receptor for *S. pneumoniae* adherence, promoting pneumococcal colonization of the airways.[17](#resp13179-bib-0017){ref-type="ref"}, [18](#resp13179-bib-0018){ref-type="ref"}, [19](#resp13179-bib-0019){ref-type="ref"} RSV has also been shown to enhance pneumococcal virulence in animal models, with co‐infection resulting in increased inflammation.[18](#resp13179-bib-0018){ref-type="ref"}, [19](#resp13179-bib-0019){ref-type="ref"}, [20](#resp13179-bib-0020){ref-type="ref"} In young children, colonization of the upper airways by *Streptococcus* species, such as *S. pneumoniae*, has also been correlated with increased disease severity and inflammation.[5](#resp13179-bib-0005){ref-type="ref"}, [6](#resp13179-bib-0006){ref-type="ref"}, [7](#resp13179-bib-0007){ref-type="ref"} However, the clinical relevance of paediatric RSV and *S. pneumoniae* co‐infections is still under debate, due to conflicting data. Some investigations have shown a clear association between positive bacterial cultures and increased admission, duration of stay and use of supportive care at hospitals and intensive care units,[8](#resp13179-bib-0008){ref-type="ref"}, [9](#resp13179-bib-0009){ref-type="ref"}, [10](#resp13179-bib-0010){ref-type="ref"}, [14](#resp13179-bib-0014){ref-type="ref"} while older and generally cross‐sectional studies have found no association between viral/bacteria co‐detection and markers of disease severity.[11](#resp13179-bib-0011){ref-type="ref"}, [12](#resp13179-bib-0012){ref-type="ref"}, [13](#resp13179-bib-0013){ref-type="ref"}, [37](#resp13179-bib-0037){ref-type="ref"}, [38](#resp13179-bib-0038){ref-type="ref"} The longitudinal study reported by Teo *et al*.,[5](#resp13179-bib-0005){ref-type="ref"} in which every ARI over the first year of life was captured using culture‐independent techniques, clearly demonstrated that colonization by bacteria such as *S. pneumoniae, H. influenzae* and *M. catarrhalis* was associated with more severe lower respiratory infections in the presence of respiratory viruses. Together, these data strongly suggest that specific viral/bacterial interactions are associated with increased disease severity.

In the present study, RSV and *S. pneumoniae* was the only co‐pathogen detection that was associated with increased disease severity. Surprisingly, while many clinical studies of paediatric ARI have reported strong positive associations between RSV and *H. influenzae* and a correlation with disease severity,[4](#resp13179-bib-0004){ref-type="ref"}, [6](#resp13179-bib-0006){ref-type="ref"}, [7](#resp13179-bib-0007){ref-type="ref"}, [8](#resp13179-bib-0008){ref-type="ref"} a positive association between these two pathogens, or an association with disease severity, was not found in this study. Likewise, no difference in overall severity of hRV ARI was observed when *S. pneumoniae* was co‐detected, despite previous reports of synergism between these two pathogens.[22](#resp13179-bib-0022){ref-type="ref"}, [23](#resp13179-bib-0023){ref-type="ref"}, [39](#resp13179-bib-0039){ref-type="ref"} Interactions between RSV and *H. influenzae*, and hRV and *S. pneumoniae* have also been identified in the upper airways of healthy young children,[36](#resp13179-bib-0036){ref-type="ref"} suggesting interaction mechanisms independent of disease.

No association was observed between the presence of multiple viruses and increased ARI severity in the present study. The prevalence and clinical significance of multiple viral infections varies depending on the viruses investigated and the cohort.[40](#resp13179-bib-0040){ref-type="ref"}, [41](#resp13179-bib-0041){ref-type="ref"}, [42](#resp13179-bib-0042){ref-type="ref"}, [43](#resp13179-bib-0043){ref-type="ref"} Studies identifying associations with increased disease severity have often used increased duration of symptoms and hospitalization stays as clinical outcomes.[41](#resp13179-bib-0041){ref-type="ref"}, [42](#resp13179-bib-0042){ref-type="ref"}, [43](#resp13179-bib-0043){ref-type="ref"}, [44](#resp13179-bib-0044){ref-type="ref"} It has been suggested that a secondary viral infection, before the primary infection has resolved, may result in an additive effect on variables like duration of symptoms.[41](#resp13179-bib-0041){ref-type="ref"} The majority of the participants in our study only attended the acute visit at the ED, thus longitudinal data, like duration of symptoms, could not be collected and the clinical effects of multiple viral infection could not be evaluated in more depth.

Season of ED visit had only a limited effect on *H. influenzae* colonization and did not affect detection of the other pathogens investigated in the present study. RSV infections are known to peak during autumn in Brisbane,[4](#resp13179-bib-0004){ref-type="ref"}, [24](#resp13179-bib-0024){ref-type="ref"} while *S. pneumoniae* infections tend to peak in winter[45](#resp13179-bib-0045){ref-type="ref"}; however, the small sample size of the present study does not allow in‐depth examination of seasonal effects. Similar to the findings of other studies, in the subset of samples with available data, childcare attendance and presence of siblings were found to influence detection of RSV, *S. pneumoniae* and *H. influenzae.* [4](#resp13179-bib-0004){ref-type="ref"}, [46](#resp13179-bib-0046){ref-type="ref"}, [47](#resp13179-bib-0047){ref-type="ref"}

Matched, healthy controls were not available in the present study, thus the interaction dynamics and the cause‐effect relationships between the identified co‐pathogens could not be investigated. Longitudinal studies, where samples are taken before, during and after ARI episodes, such as that reported by Teo *et al*.,[5](#resp13179-bib-0005){ref-type="ref"} are ideal future such investigations.

In the present study, we have provided evidence supporting a clinically relevant synergism between RSV and *S. pneumoniae* in a Brisbane‐based cohort of young children with viral ARI. Understanding the complex interactions between potential respiratory pathogens, and their short and long‐term health consequences, is important for improved diagnosis, treatment and prevention of paediatric ARI.
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**Figure S2** Pathogen detection results from the 27 nasal swabs and washes taken at the convalescent visit.

**Table S1** Criteria‐based scoring system for quantifying clinical disease severity.

**Table S2** Viral and bacterial detection qPCR assays.

**Table S3** Univariable analysis of associations between pathogen detection, clinical parameters and participant demographics.

**Table S4** Associations between pathogen detections and severity parameters with adjustment for confounding factors.

###### 

Click here for additional data file.

The authors would like to thank the following for their assistance in study management, participant recruitment, sample collection and sample processing: staff at the emergency department of the Royal Children\'s Hospital; Janine Di‐Masi and Emma Thomas at the Centre for Children\'s Health Research; and Rebecca Holding at the Queensland Paediatric Infectious Diseases Group. The study was supported in part by grants from the National Health and Medical Research Council (\#1047663) and the Australian Infectious Diseases Research Centre.
